Syngene International Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
SYNGENE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts more than Nifty Smallcap 250 and 0.9 pts more than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Syngene International has submitted a disclosure to the exchange regarding pending litigation(s) or dispute(s) involving the company, or an outcome of such matters that may impact it. The announcement follows the standard exchange requirement for listed companies to inform stakeholders about ongoing legal proceedings or material outcomes. Specific details such as the nature of the case, forum, amount involved, or the outcome direction have not been mentioned in the headline provided. Investors would need to review the full filing or the company's earlier communications to understand the financial or reputational bearing.
For shareholders, this is a routine compliance disclosure rather than a confirmed adverse event. The actual impact on stock price or business depends on the nature and quantum of the litigation, which is not clear from the limited information shared.